CONMED Corporation to Announce Fourth Quarter 2024 Financial Results on February 5, 2025
CONMED (NYSE: CNMD) has announced it will release its fourth quarter 2024 financial results after market close on Wednesday, February 5, 2025. The company will host a conference call at 4:30 p.m. ET on the same day to discuss the results. Interested parties can pre-register for the telephone conference, and a webcast will be available through the Investors section of CONMED's website. A replay of the webcast will be accessible approximately one hour after the call concludes.
CONMED (NYSE: CNMD) ha annunciato che pubblicherà i suoi risultati finanziari del quarto trimestre 2024 dopo la chiusura del mercato il mercoledì 5 febbraio 2025. L'azienda ospiterà una conferenza telefonica alle 16:30 ET lo stesso giorno per discutere i risultati. Le parti interessate possono preregistrarsi per la conferenza telefonica, e sarà disponibile una diretta web attraverso la sezione Investitori del sito web di CONMED. Una registrazione della diretta sarà accessibile circa un'ora dopo la conclusione della chiamata.
CONMED (NYSE: CNMD) ha anunciado que publicará sus resultados financieros del cuarto trimestre de 2024 después del cierre del mercado el miércoles 5 de febrero de 2025. La compañía llevará a cabo una conferencia telefónica a las 4:30 p.m. ET el mismo día para discutir los resultados. Las partes interesadas pueden preregistrarse para la conferencia telefónica, y habrá una transmisión en línea disponible a través de la sección de Inversores del sitio web de CONMED. Una grabación de la transmisión estará accesible aproximadamente una hora después de que concluya la llamada.
CONMED (NYSE: CNMD)는 2024년 4분기 재무 결과를 2025년 2월 5일 수요일 시장 종료 후 공개한다고 발표했습니다. 회사는 같은 날 오후 4시 30분 ET에 결과에 대해 논의하는 컨퍼런스 콜을 진행할 예정입니다. 관심 있는 당사자는 전화 회의에 사전 등록할 수 있으며, CONMED 웹사이트의 투자자 섹션을 통해 웹캐스트를 이용할 수 있습니다. 웹캐스트의 재생은 콜이 끝난 후 약 한 시간 후에 접근할 수 있습니다.
CONMED (NYSE: CNMD) a annoncé qu'elle publiera ses résultats financiers du quatrième trimestre 2024 après la fermeture des marchés le mercredi 5 février 2025. L'entreprise tiendra une conférence téléphonique à 16h30 ET le même jour pour discuter des résultats. Les parties intéressées peuvent se préinscrire à la conférence téléphonique, et un webinaire sera disponible via la section Investisseurs du site web de CONMED. Une rediffusion du webinaire sera accessible environ une heure après la fin de l'appel.
CONMED (NYSE: CNMD) hat angekündigt, dass die Finanzergebnisse für das vierte Quartal 2024 nach Börsenschluss am Mittwoch, den 5. Februar 2025 veröffentlicht werden. Das Unternehmen wird am selben Tag um 16:30 Uhr ET eine Telefonkonferenz abhalten, um die Ergebnisse zu diskutieren. Interessierte Parteien können sich für die Telefonkonferenz im Voraus registrieren, und ein Webcast wird über den Investorenbereich der CONMED-Website verfügbar sein. Eine Aufzeichnung des Webcasts wird ungefähr eine Stunde nach Abschluss des Anrufs zugänglich sein.
- None.
- None.
To participate in the conference call via telephone, please click here to pre-register and obtain the dial-in number and passcode.
This conference call will also be webcast and can be accessed from the “Investors” section of CONMED's website at www.conmed.com. The webcast replay of the call will be available at the same site approximately one hour after the end of the call.
About CONMED Corporation
CONMED is a medical technology company that provides devices and equipment for surgical procedures. The Company’s products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. For more information, visit www.conmed.com.
Forward-Looking Statements
This press release and associated conference call may contain forward-looking statements based on certain assumptions and contingencies that involve risks and uncertainties, which could cause actual results, performance, or trends to differ materially from those expressed in the forward-looking statements herein or in previous disclosures. For example, in addition to general industry and economic conditions, factors that could cause actual results to differ materially from those in the forward-looking statements may include, but are not limited to the risk factors discussed in the Company's Annual Report on Form 10-K for the full year ended December 31, 2023, listed under the heading Forward-Looking Statements in the Company’s most recently filed Form 10-Q and other risks and uncertainties, which may be detailed from time to time in reports filed by CONMED with the SEC. Any and all forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and relate to the Company’s performance on a going-forward basis. The Company believes that all forward-looking statements made by it have a reasonable basis, but there can be no assurance that management’s expectations, beliefs or projections as expressed in the forward-looking statements will actually occur or prove to be correct.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250106037914/en/
CONMED Corporation
Todd W. Garner
Chief Financial Officer
727-214-2975
ToddGarner@conmed.com
Source: CONMED Corporation
FAQ
When will CONMED (CNMD) report Q4 2024 earnings?
What time is CONMED's (CNMD) Q4 2024 earnings call?
How can investors access CONMED's (CNMD) Q4 2024 earnings call?
Will CONMED's (CNMD) Q4 2024 earnings call be available for replay?
